Aqr Capital Management LLC Uni Qure N.V. Transaction History

Aqr Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$5.63 - $8.27 $328,167 - $482,050	-58,289 Reduced 43.03%	77,161 $522,000
Q3 2023 Nov 14, 2023	BUY	$6.71 - $11.83 $908,869 - $1.6 Million	135,450 New	135,450 $908,000
Q2 2022 Aug 15, 2022	BUY	$13.15 - $20.45 $274,190 - $426,402	20,851 Added 31.27%	87,529 $1.63 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $457,588 - $676,626	31,471 Added 89.39%	66,678 $1.21 Million
Q4 2021 Feb 14, 2022	BUY	$20.24 - $36.01 $291,010 - $517,751	14,378 Added 69.03%	35,207 $730,000
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $541,762 - $796,084	20,829 New	20,829 $667,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.